Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
How Serious Is Ransomware?
In a recent British Medical Journal article, Krishna Chinthapalli, M.D., a neurology registrar at the National Hospital for Neurology and Neurosurgery in London, warns that hospitals need to be more prepared for ransomware attacks. Ransomware is a computer virus that sends a communication to the victim demanding money in exchange for stolen data or access. A recent report from IBM Security found a 6,000% increase in the amount of ransomware incidents from 2015 to 2016. Although the average amount extorted was between $100 and $300, the average rate of payment from victims was 70%. According to the article, many U.S. hospitals have been the targets of ransomware. Last year, one Los Angeles hospital eventually paid $17,000 to regain the use of its computer network. And in the U.K., one third of all NHS trusts have reported a ransomware attack. Although many hospitals are targeted by ransomware, many will not admit that they have had a security breach or that they have paid the cybercriminals.